The average number of persons, including directors, employed by the company during the period was as follows:

Serenatis Bio Limited is a private company limited by shares incorporated in England and Wales. The registered office is 66 Devonshire Road, Cambridge, England, CB1 2BL.

These financial statements cover the period from 9 September 2024 to 30 September 2025. This is the company's first accounting period.

The principal activity of the company continued to be that of research and experimental development on biotechnology.

For the period ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true